Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Short term Debt (2018 - 2026)

Health Catalyst filings provide 8 years of Short term Debt readings, the most recent being $1.6 million for Q1 2026.

  • On a quarterly basis, Short term Debt fell 99.3% to $1.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 million, a 99.3% decrease, with the full-year FY2025 number at $1.6 million, down 99.3% from a year prior.
  • Short term Debt hit $1.6 million in Q1 2026 for Health Catalyst, roughly flat from $1.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $231.6 million in Q1 2025 to a low of $894000.0 in Q2 2024.
  • Median Short term Debt over the past 4 years was $1.6 million (2025), compared with a mean of $70.4 million.
  • Biggest five-year swings in Short term Debt: skyrocketed 81.99% in 2025 and later plummeted 99.3% in 2026.
  • Health Catalyst's Short term Debt stood at $1.6 million in 2022, then soared by 14126.58% to $231.2 million in 2024, then crashed by 99.3% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
  • The last three reported values for Short term Debt were $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025) per Business Quant data.